Acrivon Therapeutics

Acrivon Therapeutics

Biotech company specializing in drug development through early clinical treatment success.

HQ location
Cambridge, United States
Launch date
Employees
Market cap
$37.8m
Enterprise value
($108m)
Share price
$1.19 ACRV
Authorizing premium user...